The Latest on TB and HIV
THRio Late Breaking Results from Rome IAS Conference
TB Preventive Therapy Reduces Disease and Death in People Living with HIV; Treatment is safe and effective — significant benefits at the community level.
The CREATE mission is to reduce death and disease from TB in populations with high rates of HIV AIDS.
Representing researchers, clinicians, policy makers, AIDS/TB control programs, and the community at large, the CREATE Consortium is implementing research studies to assess the impact of bold, new public health paradigms for controlling the AIDS/TB epidemic.
Led by Dr. Richard Chaisson of the Johns Hopkins Center for Tuberculosis Research, CREATE hopes to transform global policies for TB/HIV through evidence-based advocacy.
We invite you to visit our studies, Thibela, THRio, ZAMSTAR to find out how they are progressing and what impact they will have in the future of TB/HIV policies and advocacy efforts.
To see all studies at a glance, click here. Or go to a particular study on your right to learn more.